Bae, J
Hideshima, T
Zhang, G L
Zhou, J
Keskin, D B
Munshi, N C
Anderson, K C
Article History
Received: 19 May 2017
Revised: 17 September 2017
Accepted: 3 October 2017
First Online: 1 November 2017
Competing interests
: NC Munshi is an honorarium of Celgene, Millennium and Novartis; KC Anderson is an honorarium of Celgene, Millennium and Onyx; and PGR Richardson is an honorarium of Celgene, Millennium and Johnson & Johnson. NC Munshi, KC Anderson and J Bae have ownership interest and are advisory board members in OncoPep Inc. The remaining authors declare no conflict of interest.